Skip to main content
Groupe Berkem logo

Groupe Berkem — Investor Relations & Filings

Ticker · ALKEM ISIN · FR00140069V2 LEI · 969500O33I1Y9I2ZN360 PA Manufacturing
Open in API
Filings indexed 144 across all filing types
Latest filing 2022-12-19 Transaction in Own Shar…
Country FR France
Listing PA ALKEM

About Groupe Berkem

https://www.groupeberkem.com/en/

Groupe Berkem is a chemical manufacturer specializing in bio-based chemistry. The company leverages its expertise in plant extraction and chemical formulation to develop and produce sustainable solutions aimed at supporting the ecological transition. It integrates plant-based chemistry into conventional industrial processes across four main business areas: Construction & Materials, offering solutions for the protection, decoration, and maintenance of wood and mineral materials; Health, Beauty & Nutrition, providing active ingredients for the cosmetics, nutraceutical, and agri-food sectors; Hygiene & Protection; and Industry, delivering high-performance protective formulations.

Recent filings

Filing Released Lang Actions
Acquisition ou cession des actions de l'émetteur / Transactions sur actions propres (version agrégée)
Transaction in Own Shares Classification · 99% confidence The document title is "Groupe Berkem Déclaration des transactions sur actions propres du 1er au 16 décembre 2022" (Declaration of transactions on own shares from December 1st to 16th, 2022). The content details specific dates, volumes, and prices of share transactions conducted by the issuer (Groupe Berkem) on itself. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). Reviewing the definitions, Code POS (Transaction in Own Shares) is the most accurate fit. It is not a Director's Dealing (DIRS), as the transactions are by the company itself, not individual directors. The document length (7235 chars) is substantial enough that it is the report itself, not just an announcement of a report (RPA/RNS).
2022-12-19 French
Acquisition ou cession des actions de l'émetteur / Modalités de mise à disposition du descriptif du programme de rachat
Transaction in Own Shares Classification · 100% confidence The document is a press release ("COMMUNIQUÉ DE PRESSE") announcing the implementation of a share repurchase program ("Programme de rachat d'actions"). It details the maximum number of shares to be acquired, the mandate given to TP ICAP, and references the authorization obtained from the General Meeting of Shareholders. The core subject is the company buying back its own shares. This directly corresponds to the definition for 'Transaction in Own Shares' (POS). The document length is relatively short (3094 chars), but it is a substantive announcement of the action itself, not just an announcement that a report is available, making POS a better fit than RPA or RNS.
2022-12-08 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces a new exclusive partnership between Groupe Berkem and Barentz for the distribution of ingredients in the personal care market across Germany, Austria, and German-speaking Switzerland. This type of announcement, detailing a business development or strategic agreement, does not fit the specific definitions for financial reports (10-K, IR, ER), shareholder actions (AGM-R, DVA), or management changes (MANG). It is a general business update. Since it is a press release announcing a commercial agreement, and there is no specific category for 'Partnership Announcement', the most appropriate fallback category is 'Regulatory Filings' (RNS), as press releases often serve as general regulatory disclosures when a more specific category is unavailable, or it could be considered a general business update that falls under the broad 'Regulatory Filings' umbrella if it is not a formal statutory filing like a 10-K or DEF 14A. Given the options, RNS is the best fit for a general, non-statutory business announcement released to the public/market.
2022-11-28 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is explicitly titled "PRESS RELEASE" and announces a new exclusive partnership extension between Groupe Berkem and Barentz for the personal care market in specific regions. This type of announcement, detailing a business development or strategic agreement, does not fit the specific financial reporting categories (like 10-K, ER, IR) or mandatory regulatory filings (like DIRS, DIV, DEF 14A). It is a general corporate announcement regarding business operations and strategy. Since there is no specific category for 'Business Development Announcement' or 'Partnership Announcement', the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous regulatory or corporate announcements that don't fit elsewhere, although 'RPA' (Report Publication Announcement) is sometimes used for press releases, RNS is generally broader for non-financial, non-meeting related corporate news.
2022-11-28 English
Inside Information / Other news releases
Regulatory Filings Classification · 99% confidence The document is explicitly titled "PRESS RELEASE" and announces the launch of a new active ingredient, Ki'Leaft®, by Groupe Berkem's subsidiary. It details the product's properties, the R&D process, and includes quotes from management and contact information for press/investor relations. This format is characteristic of an initial announcement of a business development or product launch, which is best classified as an Earnings Release (ER) if it contained financial results, but since it is purely a product/business update without explicit financial period reporting or mandatory regulatory filing headers (like 10-K or MRQ), it fits best under the general category for corporate news announcements. Given the options, and since it is not a transcript (CT), a formal report (10-K, IR), or a specific regulatory filing like insider trading (DIRS) or capital change (CAP), it functions as a general corporate announcement. However, the closest fit for a major, non-financial-results-focused announcement that drives investor interest is often grouped with Earnings Releases (ER) or, if it were shorter and just pointed to a report, RPA. Since this is a full announcement detailing a new product, it is a significant corporate event announcement. In the absence of a specific 'Product Launch' code, and noting that it is a detailed announcement rather than just a notice of publication, I will classify it as a general corporate announcement. Since 'ER' is often used broadly for significant periodic news, and 'RNS' is the fallback, I will check if it fits ER better. ER is defined as 'Initial announcement of quarterly/periodical financial results (key highlights only)'. This document does not contain financial results. Therefore, the most appropriate fallback for a significant, non-specified corporate announcement is RNS (Regulatory Filings - general regulatory announcements and fallback category).
2022-11-09 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces the launch of a new cosmetic ingredient, Ki'Leaft®, by Groupe Berkem. It details the product's properties, R&D background, and market relevance. This type of announcement, focusing on a new product launch or significant business development communicated via a press release format, is typically classified as an Earnings Release (ER) if it contains key financial highlights, or more generally, a Regulatory Filing (RNS) if it's a general corporate announcement not fitting other specific categories like M&A or Capital Change. Since this is a product launch announcement and not a formal financial report (like 10-K or IR) or a transcript, and it doesn't fit perfectly into the other specific categories (like DIV, CAP, MANG), the most appropriate general category for a significant corporate news announcement that isn't a formal financial statement is RNS (Regulatory Filings/General Announcement). However, given the context of financial reporting databases, product launches that are not earnings-related often fall under general news releases. Since 'ER' is defined as 'Initial announcement of quarterly/periodical financial results (key highlights only)', and this is a product announcement, RNS is the best fit as a general regulatory/corporate announcement.
2022-11-09 French

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.